by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
WALTHAM, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) — TESARO, Inc. (NASDAQ:TSRO), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to niraparib for the treatment of...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
Sarasota, FL, Sept. 12, 2016 (GLOBE NEWSWIRE) — Zion Research has published a new report titled “PVC Market (Rigid PVC And Flexible PVC) by Application ( Pipes & Fittings, Wires & Cables, Films & Sheets, Bottles and Others) For Automotive, Electrical...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
NEWTON, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) — Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company, today announced the appointment of Humphrey A.R. Gardner MD, FCAP, as Senior Vice President, Clinical Development. Dr. Gardner...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
MENLO PARK, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) — Geron Corporation (Nasdaq:GERN) today provided updates on the clinical trials being conducted by Janssen Research & Development, LLC, of the telomerase inhibitor imetelstat. Planned internal reviews of...
by GlobeNewsWire | Sep 12, 2016 | Globe Newswire
CLEVELAND, Sept. 12, 2016 (GLOBE NEWSWIRE) — Athersys, Inc. (Nasdaq:ATHX) announced today the successful completion of Japan’s Pharmaceutical and Medical Devices Agency (PMDA) review of the Clinical Trial Notification (CTN), allowing the commencement by HEALIOS...